Profile-based-therapy (PBT) in schizophrenias. A preclinical indication for the use of dihydroxyphenylserine (DOPS).
D000818:Animals; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D002396:Catechols / Q000494:pharmacology / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D006801:Humans; D066298:In Vitro Techniques; D008094:Lithium / Q000494:pharmacology; D011817:Rabbits; D012559:Schizophrenia / Q000188:drug therapy* / Q000378:metabolism; D012694:Serine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D012701:Serotonin / Q000097:blood; D013997:Time Factors; D014316:Tritium
D002396:Catechols; D014316:Tritium; D012701:Serotonin; D012694:Serine; D008094:Lithium